Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor

European Heart Rhythm Association Cancelled Due to Coronavirus

More than one-third of doctors cancelling plans to attend due to travel restrictions

The European Heart Rhythm Association (EHRA) electrophysiology (EP) annual meeting cancelled due to coronavirus. #COVID19 #coronavirus #2019nCoV

March 10, 2020 — Novel coronavirus (COVID-19) has claimed another large cardiology meeting, the European Heart Rhythm Association (EHRA) has cancelled its 2020 scientific congress scheduled March 29-31 in Vienna, Austria.

The European Society of Cardiology (ESC) and EHRA leadership have been closely following the recent developments around COVID-19. With severe measures being taken by hospitals to deal with the epidemic, a rapidly growing number of congress faculty had to cancel travel plans to the conference because they are unable to travel. Many hospitals are imposing travel restrictions on their staffs to ensure they are available in case of local COVID-19 outbreaks and the hospitals needing to implement emergency plans. 

"It is clear that severe measures must be prepared, and that physicians and hospitals need to ready themselves to deal with the epidemic," said EHRA President Hein Heidbuchel, M.D., Ph.D., University of Antwerp. "As a result, over the past few days, more than a third of our congress faculty have had to cancel their participation – a number which continues to rise. We have discussed the situation with our partners who share the opinion that, under the current circumstances, cancelling EHRA 2020 is the only responsible course of action."

The ESC is now considering whether to reschedule at least some of the event for a later date or deliver some of the planned content via online platforms, such as webinars

EHRA is also working out refunds of registration fees. 

"At EHRA, our focus now is to allow you and your hospital to fight this epidemic. We wish you all the best in these uncertain times and look forward to seeing you in the future," Heidbuchel said. 

The cancellation follows on the heels of the American College of Cardiology (ACC) cancelling its large meeting this week. ACC cancelled for the same reason, because many doctors are under hospital imposed travel bans and would not be able to attend the conference. Some vendors also started to pull out of the exhibit hall prior to the cancellation Monday. Read the article ACC Cancels 2020 Conference Amid Coronavirus Concerns.

The Society of Interventional Radiology (SIR) also cancelled its meeting March 4 in Seattle because of the City of Seattle and King County Public Health Department issued new public health recommendations to help prevent the spread of the COVID-19 novel coronavirus. Among these recommendations was a request to organizers of large public gatherings to avoid bringing large groups of people together and consider postponing events and gatherings. Read the article SIR 2020 Cancelled Due to COVID-19 Outbreak in Seattle.

Last week, the large Healthcare Information and Management Systems Society (HIMSS) annual meeting was cancelled just days before it was supposed to open in Orlando Florida. The decision was made in part because dozens of vendors, including several anchor vendors, started to pull out of the conference. Attendees also started cancelling in large numbers as their hospitals began implementing travel restrictions. 

Read the article COVID-19 Cancels HIMSS Health IT Conference

COVID-19 fears also led to the European Society of Radiology announcing it is postponing its European Congress of Radiology (ECR) annual meeting that was supposed to take placed March 11-15 in Vienna, Austria. The ESC sponsored Acute Cardiovascular Care 2020 conference in Athens, Greece, was also cancelled. Numerous smaller and regional cardiology meetings are also being cancalled.

Read the article Coronavirus Fears Cancel European Cardiology and Radiology Conferences
 

Related COVID-19 Content:

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

 


Related Content

News | EP Lab

Jan. 28, 2026 — Corify Care has announced a major development in cardiac electrophysiology with the publication of its ...

Home January 29, 2026
Home
News | EP Lab

April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home April 29, 2025
Home
News | EP Lab

April 21, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will ...

Home April 21, 2025
Home
News | EP Lab

Feb. 12, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home February 14, 2025
Home
News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

June 25, 2024 — Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (announced HHNM as the ...

Home June 25, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
Subscribe Now